Thymic Carcinoma Treated by CyberKnife Stereotactic Body Radiotherapy

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2017 Apr 4

PMID 28367393

Citations 1

Authors

Yuko Harada

Shinichiro Miyazaki

Affiliations

Soon will be listed here.

Abstract

The standard treatment for advanced thymic carcinoma has not yet been established. Most patients have no symptoms until the advanced stage. Radiation therapy has been used for advanced stage cancer, usually in combination with surgery or chemotherapy; however, the survival rates are 30%-50%. We performed hypofractionated stereotactic radiotherapy with CyberKnife (Accuray, Sunnyvale, CA, USA) for 10 cases of advanced thymic cancer. All cases reached at least partial remission (PR) in two months with progression-free irradiated lesions and minimal radiation-related toxicity. It took only seven to 12 days for each therapy that did not require admission. CyberKnife is beneficial for patients even at the terminal stage.

Citing Articles

Prospective Study of Stereotactic Body Radiation Therapy for Thymoma and Thymic Carcinoma: Therapeutic Effect and Toxicity Assessment.

Hao X, Peng B, Zhou Z, Yang X Sci Rep. 2017; 7(1):13549.

PMID: 29051511 PMC: 5648828. DOI: 10.1038/s41598-017-12909-z.

References

Pukkala E, Martinsen J, Lynge E, Gunnarsdottir H, Sparen P, Tryggvadottir L . Occupation and cancer - follow-up of 15 million people in five Nordic countries. Acta Oncol. 2009; 48(5):646-790. DOI: 10.1080/02841860902913546. View

Monden Y, Nakahara K, Iioka S, Nanjo S, Ohno K, Fujii Y . Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg. 1985; 39(2):165-9. DOI: 10.1016/s0003-4975(10)62558-1. View

Venuta F, Anile M, Diso D, Vitolo D, Rendina E, De Giacomo T . Thymoma and thymic carcinoma. Eur J Cardiothorac Surg. 2009; 37(1):13-25. DOI: 10.1016/j.ejcts.2009.05.038. View

Engels E, Pfeiffer R . Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer. 2003; 105(4):546-51. DOI: 10.1002/ijc.11099. View

Siesling S, van der Zwan J, Izarzugaza I, Jaal J, Treasure T, Foschi R . Rare thoracic cancers, including peritoneum mesothelioma. Eur J Cancer. 2012; 48(7):949-60. DOI: 10.1016/j.ejca.2012.02.047. View

Uematsu M, Yoshida H, Kondo M, Itami J, Hatano K, Isobe K . Entire hemithorax irradiation following complete resection in patients with stage II-III invasive thymoma. Int J Radiat Oncol Biol Phys. 1996; 35(2):357-60. DOI: 10.1016/0360-3016(96)00086-7. View

Ohara K, Tatsuzaki H, Fuji H, Sugahara S, Okumura T, Akaogi E . Radioresponse of thymomas verified with histologic response. Acta Oncol. 1998; 37(5):471-4. DOI: 10.1080/028418698430421. View

Ogawa K, Toita T, Uno T, Fuwa N, Kakinohana Y, Kamata M . Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases. Cancer. 2002; 94(12):3115-9. DOI: 10.1002/cncr.10588. View

Scorsetti M, Leo F, Trama A, DAngelillo R, Serpico D, Macerelli M . Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016; 99:332-50. DOI: 10.1016/j.critrevonc.2016.01.012. View

10.

Fan C, Huang W, Jen Y, Lin M, Lin K . Stereotactic ablative radiotherapy with CyberKnife for advanced thymic carcinoma: a case report. Curr Oncol. 2015; 22(5):e391-4. PMC: 4608416. DOI: 10.3747/co.22.2693. View

11.

Komaki R, Gomez D . Radiotherapy for thymic carcinoma: adjuvant, inductive, and definitive. Front Oncol. 2014; 3:330. PMC: 3887269. DOI: 10.3389/fonc.2013.00330. View

12.

Detterbeck F, Parsons A . Thymic tumors. Ann Thorac Surg. 2004; 77(5):1860-9. DOI: 10.1016/j.athoracsur.2003.10.001. View

13.

Eng T, Fuller C, Jagirdar J, Bains Y, Thomas Jr C . Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys. 2004; 59(3):654-64. DOI: 10.1016/j.ijrobp.2003.11.021. View